![logo](/logos/004720.KS.webp)
PharmGen Science, Inc.
KRX:004720.KS
4,650 (KRW) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PharmGen Science, Inc. |
Symbool | 004720.KS |
Munteenheid | KRW |
Prijs | 4,655 |
Beurswaarde | 84,425,826,450 |
Dividendpercentage | 0% |
52-weken bereik | 4,590 - 7,440 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Lee Seung-Yeol |
Website | https://www.wooridulpharm.com |
An error occurred while fetching data.
Over PharmGen Science, Inc.
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It offers prescription drugs, OTC drugs, health food, and cosmetics. It offers its products in the form of tablet, hard capsule, granule and ointment, syrups, and suspension forms. The company was formerly
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)